Advances in Pharmacoepidemiology and Drug Safety

Editorial note: Advances in Pharmacoepidemiology and Drug Safety

Dr. Yu Chiang Hung Director Doctor, Department of Chinese Medicine Kaohsiung Chang Gung Memorial Hospital, Taiwan

, DOI: 10.35248/2167-1052.20.9.e105

Dear Readers,

Season’s greetings!

We are pleased to bring you the fourth issue of 2020. Along with few original papers and review papers, for this issue we decided to acknowledge the contributions during this COVID-19 crisis. We would like to appreciate your interest and supports towards the Advances in Pharmacoepidemiology and Drug Safety. We understand the tough times that everyone is facing during this pandemic, but we assure you that we do our best to provide you the quality review process at a regular pace. With that in mind, we would like to express our sincere thanks to the journal editorial team who evaluate papers, manage the publication process and respond to authors.

Thank you, too, to the editorial board members who have supported the journal since its inception and who continue to promote its growth. And to the reviewers, we appreciate the time you dedicate to ensuring papers meet our standards for scientific quality and integrity.

Our journal was founded to help junior researchers and authors from developing countries learn about the rigour involved in preparing a manuscript for publication and in getting published. We remain committed to that objective. As well, we continue to receive more papers from leading researchers from all countries, which is a testament to us commitment to quality.

Stay Safe & Healthy…!

Thank you!

With kind regards,

John Wayne,

Associate Managing Editor,

Advances in Pharmacoepidemiology and Drug Safety